ConductScience.org, home

Paper19821098

Effects of Livin gene RNA interference on apoptosis of cervical cancer HeLa cells and enhanced sensitivity to cisplatin.

Yu L and 1 other. J Huazhong Univ Sci Technolog Med Sci, 2009. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Effects of Livin gene RNA interference on apoptosis of cervical cancer HeLa cells and enhanced sensitivity to cisplatin. Papers, record 19821098. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19821098

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of Livin gene RNA interference on apoptosis of cervical cancer HeLa cells and enhanced sensitivity to cisplatin.
PubMed
Journal
J Huazhong Univ Sci Technolog Med Sci
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.15
iCite
Revised in PubMed
2021-10-20
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yu LLili
2Wang ZZehua

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adaptor Proteins, Signal TransducingMajor topic
ApoptosisMajor topic
CisplatinMajor topic
Drug Resistance, NeoplasmMajor topic
Inhibitor of Apoptosis ProteinsMajor topic
Neoplasm ProteinsMajor topic
Antineoplastic Agents
Caspase 3
Gene Expression Regulation, Neoplastic
HeLa Cells
Humans
Proto-Oncogene Proteins c-bcl-2
RNA Interference
RNA, Small Interfering
Survivin
Transfection
bcl-2-Associated X Protein

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111084335ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.Curr Biol2000https://conductscience.org/library/papers/11084335PubMed
211322947Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern.FEBS Lett2001https://conductscience.org/library/papers/11322947PubMed
315282301Upstream regulatory role for XIAP in receptor-mediated apoptosis.Mol Cell Biol2004https://conductscience.org/library/papers/15282301PubMed
415110788The gene-silencing efficiency of siRNA is strongly dependent on the local structure of mRNA at the targeted region.Biochem Biophys Res Commun2004https://conductscience.org/library/papers/15110788PubMed
511170436An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7.Biochemistry2001https://conductscience.org/library/papers/11170436PubMed
615843019Local RNA target structure influences siRNA efficacy: a systematic global analysis.J Mol Biol2005https://conductscience.org/library/papers/15843019PubMed
717237263Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy.Mol Cancer Ther2007https://conductscience.org/library/papers/17237263PubMed
811024045Livin, a novel inhibitor of apoptosis protein family member.J Biol Chem2001https://conductscience.org/library/papers/11024045PubMed
919024543[RNAi-mediated gene silencing of livin synergistic with epirubicin enhance apoptosis of human breast cancer cells].Zhonghua Yi Xue Za Zhi2008https://conductscience.org/library/papers/19024543PubMed
1017712228The therapeutic potential of survivin promoter-driven siRNA on suppressing tumor growth and enhancing radiosensitivity of human cervical carcinoma cells via downregulating hTERT gene expression.Cancer Biol Ther2007https://conductscience.org/library/papers/17712228PubMed
1115375376Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference.Cancer Gene Ther2004https://conductscience.org/library/papers/15375376PubMed
1212488298Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.Ann Oncol2003https://conductscience.org/library/papers/12488298PubMed
139027315The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis.Science1997https://conductscience.org/library/papers/9027315PubMed
1414614456Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene.Oncogene2003https://conductscience.org/library/papers/14614456PubMed
1519074843Challenge and promise: roles for Livin in progression and therapy of cancer.Mol Cancer Ther2008https://conductscience.org/library/papers/19074843PubMed
1610694814Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma.Gene Ther2000https://conductscience.org/library/papers/10694814PubMed
1717218055Livin/ML-IAP as a new target for cancer treatment.Cancer Lett2007https://conductscience.org/library/papers/17218055PubMed
1818515985Expression of splicing variants of the inhibitor of apoptosis livin in testicular germ cell tumors.Tumour Biol2008https://conductscience.org/library/papers/18515985PubMed
1910818227The RIP-like kinase, RIP3, induces apoptosis and NF-kappaB nuclear translocation and localizes to mitochondria.FEBS Lett2000https://conductscience.org/library/papers/10818227PubMed
2017125671[CMV DNA detection in plasma using real-time PCR based on the SYBR-Green I dye method].Enferm Infecc Microbiol Clin2006https://conductscience.org/library/papers/17125671PubMed

See all 24 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
28529715Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins.F1000Res2017https://conductscience.org/library/papers/28529715PubMed
27904848Silencing the livin gene enhances the cytotoxic effects of anticancer drugs on colon cancer cells.Ann Surg Treat Res2016https://conductscience.org/library/papers/27904848PubMed
26722271The effects of Livin shRNA on the response to cisplatin in HepG2 cells.Oncol Lett2015https://conductscience.org/library/papers/26722271PubMed
23029054Alteration of TEAD1 expression levels confers apoptotic resistance through the transcriptional up-regulation of Livin.PLoS One2012https://conductscience.org/library/papers/23029054PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BIRC5332PubTator's text mininghttps://conductscience.org/library/genes/332NCBI Gene
BIRC779444PubTator's text mininghttps://conductscience.org/library/genes/79444NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19821098

GET https://conductscience.org/api/papers/v1/19821098/references?page=2